Characterization of nerve growth factor-induced mechanical and thermal hypersensitivity in rats

European Journal of Pain (United Kingdom)

Volumn 17, Issue 4, 2013, Pages 469-479

  Mills, C D ^a   Nguyen, T ^a   Tanga, F Y ^a   Zhong, C ^a   Gauvin, D M ^a   Mikusa, J ^a   Gomez, E J ^a   Salyers, A K ^a   Bannon, A W ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A 784168; ANALGESIC AGENT; CELECOXIB; DICLOFENAC; DULOXETINE; GABAPENTIN; MORPHINE; MORPHINE SULFATE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN TYROSINE KINASE A; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEAT SENSITIVITY; HYPERALGESIA; HYPERSENSITIVITY; INJECTION SITE; MALE; MECHANICAL STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; STIMULUS RESPONSE; TISSUE INJURY;

AMINES; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BEHAVIOR, ANIMAL; CYCLOHEXANECARBOXYLIC ACIDS; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-AMINOBUTYRIC ACID; HYPERALGESIA; MALE; NERVE GROWTH FACTOR; PAIN THRESHOLD; PHYSICAL STIMULATION; PYRAZOLES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; SULFONES; THIOPHENES; TRPV CATION CHANNELS;

EID: 84879559468     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2012.00202.x     Document Type: Article

References (70)

1. Amann, R., Schuligoi, R., Herzeg, G., Donnerer, J. (1996). Intraplantar injection of nerve growth factor into the rat hind paw: Local edema and effects on thermal nociceptive threshold. Pain 64, 323-329.
2. Andersen, H., Arendt-Nielsen, L., Svensson, P., Danneskiold- Samsoe, B., Graven-Nielsen, T. (2008). Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans. Exp Brain Res 191, 371-382.
3. Andreev, N., Dimitrieva, N., Koltzenburg, M., McMahon, S.B. (1995). Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones. Pain 63, 109-115.
4. Banik, R.K., Subieta, A.R., Wu, C., Brennan, T.J. (2005). Increased nerve growth factor after rat plantar incision contributes to guarding behavior and heat hyperalgesia. Pain 117, 68-76.
5. Barde, Y.A. (1989). Trophic factors and neuronal survival. Neuron 2, 1525-1534.
6. Bennett, D.L., Koltzenburg, M., Priestley, J.V., Shelton, D.L., McMahon, S.B. (1998). Endogenous nerve growth factor regulates the sensitivity of nociceptors in the adult rat. Eur J Neurosci 10, 1282-1291.
7. Chaplan, S.R., Bach, F.W., Pogrel, J.W., Chung, J.M., Yaksh, T.L. (1994). Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53, 55-63.
8. Cheng, J.K., Ji, R.R. (2008). Intracellular signaling in primary sensory neurons and persistent pain. Neurochem Res 33, 1970- 1978.
9. Cui, M., Honore, P., Zhong, C., Gauvin, D., Mikusa, J., Hernandez, G., Chandran, P., Gomtsyan, A., Brown, B., Bayburt, E.K., Marsh, K., Bianchi, N., McDonald, H., Niforatos, W., Neelands, T.R., Moreland, R.B., Decker, M.W., Lee, C.-H., Sullivan, J.P., Faltynek, C.R. et al. (2006). TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci 26, 9385-9393.
10. Delafoy, L., Raymond, F., Doherty, A.M., Eschalier, A., Diop, L. (2003). Role of nerve growth factor in the trinitrobenzene sulfonic acid-induced colonic hypersensitivity. Pain 105, 489- 497.
11. Dixon, W.J. (1965). The up-and-down method for small samples. Am Stat Assoc J 60, 967-978.
12. Donnerer, J., Liebmann, I., Schicho, R. (2005). Differential regulation of 3-beta-hydroxysteroid dehydrogenase and vanilloid receptor TRPV1 mRNA in sensory neurons by capsaicin and NGF. Pharmacology 73, 97-101.
13. Donnerer, J., Schuligoi, R., Stein, C. (1992). Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 49, 693-698.
14. Dyck, P.J., Peroutka, S., Rask, C., Burton, E., Baker, M.K., Lehman, K.A., Gillen, D.A., Hokanson, J.L., O'Brien, P.C. (1997). Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 48, 501-505.
15. Evans, R.J., Moldwin, R.M., Cossons, N., Darekar, A., Mills, I.W., Scholfield, D. (2011). Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis. J Urol 185, 1716-1721.
16. Fjell, J., Cummins, T.R., Davis, B.M., Albers, K.M., Fried, K., Waxman, S.G., Black, J.A. (1999a). Sodium channel expression in NGF-overexpressing transgenic mice. J Neurosci Res 57, 39-47.
17. Fjell, J., Cummins, T.R., Dib-Hajj, S.D., Fried, K., Black, J.A., Waxman, S.G. (1999b). Differential role of GDNF and NGF in the maintenance of two TTX-resistant sodium channels in adult DRG neurons. Brain Res Mol Brain Res 67, 267-282.
18. Fjell, J., Cummins, T.R., Fried, K., Black, J.A., Waxman, S.G. (1999c). In vivo NGF deprivation reduces SNS expression and TTX-R sodium currents in IB4-negative DRG neurons. J Neurophysiol 81, 803-810.
19. Gerber, R.K., Nie, H., Arendt-Nielsen, L., Curatolo, M., Graven- Nielsen, T. (2011). Local pain and spreading hyperalgesia induced by intramuscular injection of nerve growth factor are not reduced by local anesthesia of the muscle. Clin J Pain 27, 240-247.
20. Goedert, M., Otten, U., Hunt, S.P., Bond, A., Chapman, D., Schlumpf, M., Lichtensteiger, W. (1984). Biochemical and anatomical effects of antibodies against nerve growth factor on developing rat sensory ganglia. Proc Natl Acad Sci U S A 81, 1580-1584.
21. Gould, H.J. 3rd, Gould, T.N., England, J.D., Paul, D., Liu, Z.P., Levinson, S.R. (2000). A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain. Brain Res 854, 19-29.
22. Halvorson, K.G., Kubota, K., Sevcik, M.A., Lindsay, T.H., Sotillo, J.E., Ghilardi, J.R., Rosol, T.J., Boustany, L., Shelton, D.L., Mantyh, P.W. (2005). A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res 65, 9426-9435.
23. Hargreaves, K., Dubner, R., Brown, F., Flores, C., Joris, J. (1988). A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77-88.
24. Hathway, G.J., Fitzgerald, M. (2006). Time course and dosedependence of nerve growth factor-induced secondary hyperalgesia in the mouse. J Pain 7, 57-61.
25. Ji, R.R., Samad, T.A., Jin, S.X., Schmoll, R., Woolf, C.J. (2002). p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36, 57-68.
26. Jing, Y.Y., Wang, J.Y., Li, X.L., Wang, Z.H., Pei, L., Pan, M.M., Dong, X.P., Fan, G.X., Yuan, Y.K. (2009). Nerve growth factor of red nucleus involvement in pain induced by spared nerve injury of the rat sciatic nerve. Neurochem Res 34, 1612- 1618.
27. Johnson, E.M.Jr. (1986). The role of NGF in sensory neurons in vivo. Trends Neurosci 16, 33-37.
28. Johnson, E.M. Jr, Gorin, P.D., Brandeis, L.D., Pearson, J. (1980). Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibody to nerve growth factor. Science 210, 916-918.
29. Katz, N., Borenstein, D.G., Birbara, C., Bramson, C., Nemeth, M.A., Smith, M.D., Brown, M.T. (2011). Efficacy and safety of tanezumab in the treatment of chronic low back pain. Pain 152, 2248-2258.
30. Lane, N.E., Schnitzer, T.J., Birbara, C.A., Mokhtarani, M., Shelton, D.L., Smith, M.D., Brown, M.T. (2010). Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med 363, 1521-1531.
31. Lewin, G.R., Mendell, L.M. (1993). Nerve growth factor and nociception. Trends Neurosci 16, 353-359.
32. Lewin, G.R., Ritter, A.M., Mendell, L.M. (1993). Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 13, 2136-2148.
33. Lewin, G.R., Rueff, A., Mendell, L.M. (1994). Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci 6, 1903-1912.
34. Lewin, G.R., Winter, J., McMahon, S.B. (1992). Regulation of afferent connectivity in the adult spinal cord by nerve growth factor. Eur J Neurosci 4, 700-707.
35. Lindsay, R.M. (1988). Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J Neurosci 8, 2394-2405.
36. Ma, Q.P., Woolf, C.J. (1997). The progressive tactile hyperalgesia induced by peripheral inflammation is nerve growth factor dependent. Neuroreport 8, 807-810.
37. Malik-Hall, M., Dina, O.A., Levine, J.D. (2005). Primary afferent nociceptor mechanisms mediating NGF-induced mechanical hyperalgesia. Eur J Neurosci 21, 3387-3394.
38. Matsuda, H., Koyama, H., Sato, H., Sawada, J., Itakura, A., Tanaka, A., Matsumoto, M., Konno, K., Ushio, H., Matsuda, K. (1998). Role of nerve growth factor in cutaneous wound healing: Accelerating effects in normal and healing-impaired diabetic mice. J Exp Med 187, 297-306.
39. McMahon, S.B., Bennett, D.L., Priestley, J.V., Shelton, D.L. (1995). The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat Med 1, 774-780.
40. Michael, G.J., Averill, S., Nitkunan, A., Rattray, M., Bennett, D.L., Yan, Q., Priestley, J.V. (1997). Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 17, 8476-8490.
41. Mills, C., Leblond, D., Joshi, S., Zhu, C., Hsieh, G., Jacobson, P., Meyer, M., Decker, M. (2012). Estimating efficacy and drug ED(50)'s using von Frey thresholds: Impact of Weber's law and log transformation. J Pain 13, 519-523.
42. Petty, B.G., Cornblath, D.R., Adornato, B.T., Chaudhry, V., Flexner, C., Wachsman, M., Sinicropi, D., Burton, L.E., Peroutka, S.J. (1994). The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 36, 244-246.
43. Pezet, S., McMahon, S.B. (2006). Neurotrophins: Mediators and modulators of pain. Annu Rev Neurosci 29, 507-538.
44. Pezet, S., Onteniente, B., Jullien, J., Junier, M.P., Grannec, G., Rudkin, B.B., Calvino, B. (2001). Differential regulation of NGF receptors in primary sensory neurons by adjuvantinduced arthritis in the rat. Pain 90, 113-125.
45. Priestley, J.V., Michael, G.J., Averill, S., Liu, M., Willmott, N. (2002). Regulation of nociceptive neurons by nerve growth factor and glial cell line derived neurotrophic factor. Can J Physiol Pharmacol 80, 495-505.
46. Ramer, M.S., Bisby, M.A. (1999). Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: Distinct mechanisms revealed by anti-NGF treatment. Eur J Neurosci 11, 837-846.
47. Ritter, A.M., Lewin, G.R., Kremer, N.E., Mendell, L.M. (1991). Requirement for nerve growth factor in the development of myelinated nociceptors in vivo. Nature 350, 500-502.
48. Ro, L.S., Chen, S.T., Tang, L.M., Jacobs, J.M. (1999). Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain 79, 265-274.
49. Rukwied, R., Mayer, A., Kluschina, O., Obreja, O., Schley, M., Schmelz, M. (2010). NGF induces non-inflammatory localized and lasting mechanical and thermal hypersensitivity in human skin. Pain 148, 407-413.
50. Saade, N.E., Massaad, C.A., Ochoa-Chaar, C.I., Jabbur, S.J., Safieh-Garabedian, B., Atweh, S.F. (2002). Upregulation of proinflammatory cytokines and nerve growth factor by intraplantar injection of capsaicin in rats. J Physiol 545, 241-253.
51. Sabsovich, I., Wei, T., Guo, T.Z., Zhao, R., Shi, X., Li, X., Yeomans, D.C., Klyukinov, M., Kingery, W.S., Clark, J.D. (2008). Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain 138, 47-60.
52. Schnitzer, T.J., Lane, N.E., Birbara, C., Smith, M.D., Simpson, S.L., Brown, M.T. (2011). Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain. Osteoarthritis Cartilage 19, 639-646.
53. Sevcik, M.A., Ghilardi, J.R., Peters, C.M., Lindsay, T.H., Halvorson, K.G., Jonas, B.M., Kubota, K., Kuskowski, M.A., Boustany, L., Shelton, D.L., Mantyh, P.W. (2005). Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain 115, 128-141.
54. Shelton, D.L., Zeller, J., Ho, W.H., Pons, J., Rosenthal, A. (2005). Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain 116, 8-16.
55. Shu, X., Mendell, L.M. (1999). Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin. Neurosci Lett 274, 159-162.
56. Svensson, P., Cairns, B.E., Wang, K., Arendt-Nielsen, L. (2003). Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain 104, 241-247.
57. Svensson, P., Castrillon, E., Cairns, B.E. (2008a). Nerve growth factor-evoked masseter muscle sensitization and perturbation of jaw motor function in healthy women. J Orofac Pain 22, 340-348.
58. Svensson, P., Wang, K., Arendt-Nielsen, L., Cairns, B.E. (2008b). Effects of NGF-induced muscle sensitization on proprioception and nociception. Exp Brain Res 189, 1-10.
59. Svensson, P., Wang, M.W., Dong, X.D., Kumar, U., Cairns, B.E. (2010). Human nerve growth factor sensitizes masseter muscle nociceptors in female rats. Pain 148, 473-480.
60. Taiwo, Y.O., Levine, J.D., Burch, R.M., Woo, J.E., Mobley, W.C. (1991). Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor. Proc Natl Acad Sci U S A 88, 5144-5148.
61. Te, A.E. (2011). A study to investigate tanezumab in patients with interstitial cystitis/painful bladder syndrome. Curr Urol Rep 12, 245-246.
62. Thompson, S.W., Dray, A., McCarson, K.E., Krause, J.E., Urban, L. (1995). Nerve growth factor induces mechanical allodynia associated with novel A fibre-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat. Pain 62, 219-231.
63. Ugolini, G., Marinelli, S., Covaceuszach, S., Cattaneo, A., Pavone, F. (2007). The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. Proc Natl Acad Sci U S A 104, 2985-2990.
64. Verge, V.M., Richardson, P.M., Benoit, R., Riopelle, R.J. (1989). Histochemical characterization of sensory neurons with highaffinity receptors for nerve growth factor. J Neurocytol 18, 583-591.
65. Weinkauf, B., Obreja, O., Schmelz, M., Rukwied, R. (2011). Differential effects of lidocaine on nerve growth factor (NGF)- evoked heat- and mechanical hyperalgesia in humans. Eur J Pain 16, 543-549.
66. Woolf, C.J., Safieh-Garabedian, B., Ma, Q.P., Crilly, P., Winter, J. (1994). Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience 62, 327- 331.
67. Xue, Q., Jong, B., Chen, T., Schumacher, M.A. (2007). Transcription of rat TRPV1 utilizes a dual promoter system that is positively regulated by nerve growth factor. J Neurochem 101, 212-222.
68. Yip, H.K., Rich, K.M., Lampe, P.A., Johnson, E.M. Jr. (1984). The effects of nerve growth factor and its antiserum on the postnatal development and survival after injury of sensory neurons in rat dorsal root ganglia. J Neurosci 4, 2986-2992.
69. Zhu, W., Galoyan, S.M., Petruska, J.C., Oxford, G.S., Mendell, L.M. (2004). A developmental switch in acute sensitization of small dorsal root ganglion (DRG) neurons to capsaicin or noxious heating by NGF. J Neurophysiol 92, 3148-3152.
70. Zimmermann, M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109-110.